Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative TPF chemotherapy in locally advanced resectable oral cavity squamous cell cancer
2010-021658-21Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Aug 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, cisplatin and fluorouracil in Oral Mucosal Carcinoma, sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoint: Pathological complete response rate. Started Aug 2010; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
Oral Mucosal Carcinoma
Beyond the preview
Go deeper on 2010-021658-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021658-21.